The project aims to support public health and enhance the protection of socially vulnerable groups by supplying healthcare institutions with humanitarian medicines for further distribution to patients free of charge and on a non-discriminatory basis
To support public health and strengthen the protection of socially vulnerable groups by providing healthcare institutions with humanitarian medicines for further free and non-discriminatory distribution to patients
Among the beneficiaries, the following categories can be distinguished:
We seek to strengthen the capacity of Ukraine’s public healthcare system to meet the needs of medical institutions for essential medicines, equipment, and medical supplies. Our goal is not only to respond to crises but to provide systematic support to the national healthcare system so that it remains a reliable pillar for millions of Ukrainians
The provision of humanitarian medicines makes it possible to:
This charitable initiative is an expression of care and unity in action. We sincerely thank our partners, healthcare professionals, and volunteers who contribute to restoring dignity and protecting people’s health
Total weight of humanitarian medicines delivered to healthcare institutions of Ukraine, kg
Estimated value of humanitarian aid, UAH
Number of healthcare institutions covered by the project
Number of beneficiaries who received humanitarian medicines within the project
Estimated value of humanitarian aid provided in 2022, UAH:
Estimated value of humanitarian aid provided in 2023, UAH:
Estimated value of humanitarian aid provided in 2024, UAH:
Estimated value of humanitarian aid provided in 2025, UAH:
With the assistance of the charitable organization Direct Relief (USA) and the support of the Embassy of Ukraine in the United States of America, a humanitarian shipment of monoclonal antibody medicines was delivered to Ukraine. The shipment included the COVID-19 treatment combination Bamlanivimab 20,000 doses and Etesevimab 40,000 doses
Total estimated value of humanitarian aid, UAH
Number of patients who received treatment
Project Partners: Direct Relief (USA), Public Health Center of the Ministry of Health of Ukraine
Project Objective: to supply healthcare institutions of Ukraine with specialized medicines Ethambutol, Pyrazinamide, and Rifampicin for tuberculosis treatment in accordance with established treatment protocols, ensuring access to essential medicines and supporting tuberculosis treatment programs
Procurement details: Ethambutol, Pyrazinamide, and Rifampicin were purchased from the Public Joint Stock Company Scientific and Production Center Borshchahivskiy Chemical and Pharmaceutical Plant, the only manufacturer of these medicines in Ukraine
Total weight of humanitarian aid, kg
Number of medicine packages provided to patients free of charge
Total estimated value of humanitarian aid, UAH
To provide specialized equipment, medicines including Emavayl, and related laboratory materials to improve the diagnosis and treatment of patients with chronic kidney failure undergoing peritoneal dialysis
Within the project, 80 Anker charging stations and necessary accessories for patients undergoing peritoneal dialysis were purchased and delivered. Medicines were procured and distributed, including a 2.5 month supply of erythropoietin, along with related laboratory materials for patients receiving peritoneal dialysis
Number of charging stations provided to ensure peritoneal dialysis during power outages
Number of laboratory materials and supplies delivered for patients undergoing peritoneal dialysis
Estimated value of humanitarian aid provided for peritoneal dialysis treatment, UAH
